Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShort-Term Debt issuances
Ratios

Aytu Biopharma (AYTU) Accumulated Depreciation & Amortization: 2015-2025

Historic Accumulated Depreciation & Amortization for Aytu Biopharma (AYTU) over the last 11 years, with Sep 2025 value amounting to $735,000.

  • Aytu Biopharma's Accumulated Depreciation & Amortization fell 60.59% to $735,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year decrease of 71.93%. This contributed to the annual value of $714,000 for FY2025, which is 66.40% down from last year.
  • Latest data reveals that Aytu Biopharma reported Accumulated Depreciation & Amortization of $735,000 as of Q3 2025, which was up 2.94% from $714,000 recorded in Q2 2025.
  • Over the past 5 years, Aytu Biopharma's Accumulated Depreciation & Amortization peaked at $3.7 million during Q2 2023, and registered a low of -$1.6 million during Q3 2021.
  • Moreover, its 3-year median value for Accumulated Depreciation & Amortization was $1.9 million (2023), whereas its average is $2.0 million.
  • Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first tumbled by 6,866.67% in 2021, then skyrocketed by 2,458.82% in 2022.
  • Over the past 5 years, Aytu Biopharma's Accumulated Depreciation & Amortization (Quarterly) stood at -$1.2 million in 2021, then skyrocketed by 351.56% to $3.1 million in 2022, then rose by 0.46% to $3.1 million in 2023, then tumbled by 78.85% to $651,000 in 2024, then crashed by 60.59% to $735,000 in 2025.
  • Its last three reported values are $735,000 in Q3 2025, $714,000 for Q2 2025, and $690,000 during Q1 2025.